A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation
A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation
批准号:
10696252
负责人:
Scott Dryden-Peterson
金额:
$46.95万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-19 至 2024-08-31
关键词:
AccountingAdultAdvanced Malignant NeoplasmAffectAfrica South of the SaharaAgeAnusAwarenessBotswanaBreastBreast Cancer CellBreast Cancer Early DetectionCancer BurdenCancer DetectionCancer PatientCaringCause of DeathCervix UteriCessation of lifeClinicCommunitiesComplexCounselingCountryDiagnosisDiagnosticDiseaseEarly DiagnosisEducationEffectivenessFamilyGeographyHIVHIV diagnosisHead and Neck Squamous Cell CarcinomaHead and neck structureHealth systemHealthcareIncidenceIncomeIndividualInternationalInterventionKnowledgeLimited StageMalignant NeoplasmsMedicalMentorsModelingNursesOncologyPathologyPathway interactionsPatient advocacyPatientsPersonsPhasePhysiciansPopulationPrevalencePrimary CarePrinted MediaProbabilityProviderQualitative ResearchRandomizedReach, Effectiveness, Adoption, Implementation, and MaintenanceRecordsResearchResource-limited settingResourcesRural CommunityScheduleScreening for cancerSelf EfficacySocial WorkersSpeedSymptomsSyndromeTimeTransportationVaginaViralVital StatusVulvaagedcancer carecancer diagnosiscancer initiationcancer riskcancer survivalcancer therapycare seekingcohortcommon symptomcurative treatmentseffectiveness evaluationeffectiveness testingeffectiveness/implementation trialfamily supportimplementation evaluationimplementation interventionimprovedinnovationlow and middle-income countriesmedical care feesmortalitymultidisciplinarypandemic diseasepatient engagementpatient navigationpenispilot trialprogramsresponserural dwellersself helptheories
中文摘要
项目总结/文摘
英文摘要
Project Summary/Abstract
The HIV pandemic has intensified the growing burden of cancer in low- and middle-income countries (LMICs),
where nearly three-quarters of all cancer deaths occur. The majority of patients in LMICs have advanced cancer
stage and limited opportunity for survival. Meaningful improvements in cancer mortality in LMICs will require
prompt diagnosis and efficient linkage to care, however research identifying effective strategies has not been
conducted. Botswana has key resources in place— free-of-charge medical care including comprehensive cancer
care, accessible primary clinics, and an internationally-emulated ART program— yet large gaps in timely
cancer care and thus provides a key opportunity to innovate strategies to detect cancer earlier and engage
patients in care. The Potlako pilot trial (ORBIT phase IIa), evaluating an intervention targeting diagnostic and
pre-treatment intervals in a single district (27 communities) in Botswana, has successfully increased the
number of patients entering cancer care and number treated with curative intent compared to historical
controls. As a next step, the Potlako+ trial— a community-randomized (26 geographically diverse rural
communities, 1:1), pragmatic, ORBIT phase IIb, type 1 hybrid effectiveness-implementation trial— will assess a
complex, theory-informed intervention to promote earlier clinic presentation with symptoms suggestive of
cancer, enable efficient diagnosis, and facilitate prompt initiation of oncologic treatment. The Potlako+ trial
targets high burden cancers accounting for 60% of cancer deaths (breast, cervix, anus, penis, vulva, and head
and neck) which are typically curable with early detection of symptoms. We utilize cancer stage at time of
treatment initiation, incidence of curative intent treatment, and the duration of Models of Pathways to
Treatment intervals as primary effectiveness endpoints. Implementation will be evaluated using the RE-AIM
framework. The project will achieve three aims: 1) Assess the effectiveness of cancer symptom awareness
intervention with rural residents (persons living with HIV and HIV-uninfected) aged 30 years and older in
decreasing time to presentation with moderate and high probability cancer syndromes, 2) Assess impact of a
comprehensive cancer patient navigation platform on reducing time to diagnosis and initiation of cancer
treatment (diagnostic and pre-treatment intervals), and 3) Evaluate whether the combined multilevel
intervention improves early stage treatment and cumulative incidence of curative intent treatment.
Understanding the impact and implementation of these interventions will inform strategies of care for LMIC
populations at increasing risk of cancer death and contribute to developing models of primary care in resource-
constrained environments.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1200/go.21.00209
发表时间:
2021-09
期刊:
JCO global oncology
影响因子:
4.5
作者:
[Chipidza FE, Kayembe MKA, Nkele I, Efstathiou JA, Chabner BA, Abramson J, Dryden-Peterson SL, Sohani AR]
通讯作者:
Sohani AR
At-home Testing and Risk Factors for Acquisition of SARS-CoV-2 Infection in a Major US Metropolitan Area.
美国主要大都市地区 SARS-CoV-2 感染的家庭检测和风险因素。
DOI:
10.1101/2022.02.02.22269258
发表时间:
2022
期刊:
medRxiv : the preprint server for health sciences
影响因子:
--
作者:
[Woolley,AnnE, Dryden-Peterson,Scott, Kim,Andy, Naz-McLean,Sarah, Kelly,Christina, Laibinis,HannahH, Bagnall,Josephine, Livny,Jonathan, Ma,Peijun, Orzechowski,Marek, Shoresh,Noam, Gabriel,Stacey, Hung,DeborahT, Cosimi,LisaA]
通讯作者:
Cosimi,LisaA
DOI:
10.1007/s11606-023-08106-6
发表时间:
2023-05
期刊:
JOURNAL OF GENERAL INTERNAL MEDICINE
影响因子:
5.7
作者:
[Benchimol-Elkaim, Brandon, Dryden-Peterson, Scott, Miller, Donald R., Koh, Howard K., Geller, Alan C.]
通讯作者:
Geller, Alan C.
A Novel Approach to Equitable Distribution of Scarce Therapeutics: Institutional Experience Implementing a Reserve System for Allocation of COVID-19 Monoclonal Antibodies.
稀缺治疗学的公平分布的一种新颖方法:实施储备系统的机构经验,用于分配Covid-19,单克隆抗体。
DOI:
10.1016/j.chest.2021.08.003
发表时间:
2021-12
期刊:
Chest
影响因子:
9.6
作者:
[Rubin E, Dryden-Peterson SL, Hammond SP, Lennes I, Letourneau AR, Pathak P, Sonmez T, Ünver MU]
通讯作者:
Ünver MU
DOI:
10.1371/journal.pone.0269127
发表时间:
2022
期刊:
PloS one
影响因子:
3.7
作者:
[]
通讯作者:
Botswana CASCADE Clinical Trials Site
-
批准号:10544424
-
项目类别:
-
资助金额:$25.78万
-
财政年份:2022
-
负责人:Scott Dryden-Peterson
-
依托单位:
A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation
-
批准号:10020924
-
项目类别:
-
资助金额:$47.84万
-
财政年份:2019
-
负责人:Scott Dryden-Peterson
-
依托单位:
Covid-19-related cervical cancer treatment interruption and role of neoadjuvant chemotherapy
-
批准号:10381101
-
项目类别:
-
资助金额:$13.6万
-
财政年份:2019
-
负责人:Scott Dryden-Peterson
-
依托单位:
A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation
-
批准号:10242834
-
项目类别:
-
资助金额:$47.91万
-
财政年份:2019
-
负责人:Scott Dryden-Peterson
-
依托单位:
A multilevel intervention (Potlako+) to improve timely cancer detection and treatment initiation
-
批准号:10478285
-
项目类别:
-
资助金额:$48.07万
-
财政年份:2019
-
负责人:Scott Dryden-Peterson
-
依托单位:
Risk factors for early morbidity and mortality of HIV-exposed uninfected infants
-
批准号:8262976
-
项目类别:
-
资助金额:$13.69万
-
财政年份:2012
-
负责人:Scott Dryden-Peterson
-
依托单位:
Risk factors for early morbidity and mortality of HIV-exposed uninfected infants
-
批准号:8868893
-
项目类别:
-
资助金额:$12.85万
-
财政年份:2012
-
负责人:Scott Dryden-Peterson
-
依托单位:
Risk factors for early morbidity and mortality of HIV-exposed uninfected infants
-
批准号:8505366
-
项目类别:
-
资助金额:$13.38万
-
财政年份:2012
-
负责人:Scott Dryden-Peterson
-
依托单位:
Risk factors for early morbidity and mortality of HIV-exposed uninfected infants
-
批准号:9086206
-
项目类别:
-
资助金额:$12.77万
-
财政年份:2012
-
负责人:Scott Dryden-Peterson
-
依托单位:
Risk factors for early morbidity and mortality of HIV-exposed uninfected infants
-
批准号:8686729
-
项目类别:
-
资助金额:$13.16万
-
财政年份:2012
-
负责人:Scott Dryden-Peterson
-
依托单位:
海外基金